Awapatent
Awapatent is one of Europe´s leading consultancy firms in the field of IPR (Intellectual Property Rights).

One of the firm’s objectives is to help clients establish competitive positions through trademarks, patents and other proprietary rights. Another fast-growing area of practice is strategic IPR planning and risk analysis activities in preparation of stock exchange introductions and acquisitions. The firm has a staff of more than 100 consultants specialised in key science and technology fields. Several of our consultants hold a doctor’s degree in their area of expertise. The staff also comprises 25 attorneys at law, specialised in litigation and proceedings in intellectual property matters.

The main areas of growth for our clients are IT and Life Sciences, the focus being on biotechnology, pharmaceutical products, bio informatics and bio law.

Awapatent has a dynamic age structure – the average age is currently 39 years – and runs its own Trainee Programme for newly recruited consultants. In addition to this, all the firm’s consultants are involved in structured in-service training.

For companies in the Medicon Valley our offices in Copenhagen, Malmö and Helsingborg are particularly well situated, but we also have offices in Stockholm, Gothenburg, Växjö, Söderhamn and Halmstad as well as a global network of partners.

Your company has made a technical breakthrough. We have the IPR knowledge required. Together we can strengthen your company’s competitive positions – for stronger cash flow and future added value.

Biotech valley
The core of both commercial and research activities related to Swedish bio-technology can be found in the greater Stockholm area.

Five major universities, university colleges and several smaller research and education facilities are located here and also all major research funding organisations. This area is often described as the Biotech Valley of Sweden.

Strängnäs
Strängnäs is a small town west of Stockholm, easily reached in 45 minutes with the high speed train. This town has been associated with biotechnology and production of phar-maceutical substances for more than 50 years.

Today, the leading biotech company is Phar-macia corporation. The Strängnäs plant is a core facility for biotech production for the company. The annual market value of the pharma-ceutical products marketed here is close to 1 billion U$.

In addition to Pharmacia, both DSM Anti-Infectives and AstraZeneca have production facilities in Strängnäs. These companies are supported by a number of smaller service companies. A new trend is - that new and growing biotech companies have located activities related to production in Strängnäs. These companies benefit from using the BCS laboratory, a combined teaching and project / research laboratory set up jointly by the local industry, Malardalen University in Eskilstuna and local secondary educators. A new initiative focused on the manufacturing of biotechnology based products is now also being launched.